NEW YORK (GenomeWeb) – Scientists from Toronto's Hospital for Sick Children (Sick Kids) have led a study showing several ways in which CRISPR/Cas9 genome editing could be used to treat hereditary diseases. Among the various applications demonstrated, the researchers used CRISPR/Cas9 to remove exon duplication in a gene affecting a patient with Duchenne Muscular Dystrophy (DMD), leading to the production of regular dystrophin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.